+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fosaprepitant"

From
Antiemetics and Antinauseants Market Report 2025 - Product Thumbnail Image

Antiemetics and Antinauseants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Fosaprepitant is a drug used in the treatment of gastrointestinal disorders. It is a prodrug of aprepitant, a neurokinin-1 (NK-1) receptor antagonist, and is used to prevent nausea and vomiting caused by chemotherapy. Fosaprepitant is administered intravenously and is available in both single-dose and multiple-dose vials. It is typically used in combination with other antiemetic drugs, such as ondansetron and dexamethasone. Fosaprepitant has been shown to be effective in reducing the incidence of nausea and vomiting in patients receiving chemotherapy. Fosaprepitant is marketed by several pharmaceutical companies, including Merck & Co., Inc., Teva Pharmaceuticals, and Sun Pharmaceutical Industries Ltd. It is also available as a generic drug in some countries. Show Less Read more